SL 2024-04-01T130131.04 Report

.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
Ref By : CGHS Gender : Male
Collected : 1/4/2024 8:00:00AM Reported : 1/4/2024 12:55:14PM
A/c Status : P Report Status : Final
Collected at : LPL-SONIPAT Processed at : Dr. Lal PathLabs Ltd.
S-87 . S-87 .
Test Report
Test Name Results Units Bio. Ref. Interval
LIPID PROFILE, BASIC, SERUM

(Colorimetry Enzymatic)
Cholesterol Total 214 mg/dL <200.00
Triglycerides 223 mg/dL <150.00
HDL Cholesterol 47 mg/dL >40.00
LDL Cholesterol,Direct 153 mg/dL <100.00
VLDL Cholesterol 45 mg/dL <30.00
Non-HDL Cholesterol 167 mg/dL <130.00
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for
Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors
ASCVD Risk Stratification & Treatment goals in Indian population

1. Indians are at very high risk of developing ASCVD, they usually get the disease at an early age,
have a more severe form of the disease and have poorer outcome as compared to the western
populations
2. Many individuals remain asymptomatic before they get heart attack, ASCVD risk helps to identify
high risk individuals even when there is no symptom related to heart disease
3. ASCVD risk category helps clinician to decide when to consider therapy and what should be the
treatment goal
Treatment Goals as per Lipid Association of India 2020
*466334874* Page 1 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report

--------------------------------------------------------------------------------------------
| | CONSIDER THERAPY | TREATMENT GOAL |
| ASCVD RISK |-------------------------------------|----------------------------------------|
| CATEGORY@ | LDL CHOLESTEROL| NON HDL CHLOESTEROL| LDL CHOLESTEROL | NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) |(NON HDL-C) (mg/dL |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (A) | >=50 | >=80 |<50 (Indispensable)| <80 |
| | | |<30 (Optional) | |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (B) | >=30 | >=60 | <30 | <60 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Very High | >=50 | >=80 | <50 | <80 |
|--------------|----------------|--------------------|-------------------|--------------------|
| High | >=70 | >=100 | <70 | <100 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Moderate | >=100 | >=130 | <100 | <130 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Low | >=130* | >=160* | <100 | <130 |
---------------------------------------------------------------------------------------------
* In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months
@To know your risk category click on bit.ly link sent on your registered mobile number, answer the
questionnaire, the ASCVD risk report can be downloaded from website
LIVER PANEL 1; LFT,SERUM

(Reflectance Photometry)
AST (SGOT) 44.0 U/L <50
ALT (SGPT) 92.0 U/L <50
AST:ALT Ratio 0.48 <1.00
GGTP 58.2 U/L <55
Alkaline Phosphatase (ALP) 86.00 U/L 30 - 120
Bilirubin Total 0.48 mg/dL 0.30 - 1.20
Bilirubin Direct 0.08 mg/dL 0.00 - 0.40
Bilirubin Indirect 0.40 mg/dL <1.10
Total Protein 8.22 g/dL 6.40 - 8.30
Albumin 4.53 g/dL 3.50 - 5.20
*466334874* Page 2 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report

A : G Ratio 1.23 0.90 - 2.00
Note
1. In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of
increased AST, ALT levels. NAFLD is considered as hepatic manifestation of metabolic syndrome.
2. In most type of liver disease, ALT activity is higher than that of AST; exception may be seen in Alcoholic
Hepatitis, Hepatic Cirrhosis, and Liver neoplasia. In a patient with Chronic liver disease, AST:ALT
ratio>1 is highly suggestive of advanced liver fibrosis.
3. In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD,
Enhanced liver fibrosis (ELF) test may be used to evaluate liver fibrosis.
4. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can
be used to assess risk for development of Hepatocellular Carcinoma.
KIDNEY PANEL; KFT,SERUM

(Reflectance Photometry,Direct ISE)
Creatinine 0.84 mg/dL 0.67 - 1.17
GFR Estimated 119 mL/min/1.73m2 >59
GFR Category G1
Urea 23.70 mg/dL 17.00 - 43.00
Urea Nitrogen Blood 11.07 mg/dL 6.00 - 20.00
BUN/Creatinine Ratio 13
Uric Acid 6.09 mg/dL 3.50 - 7.20
Total Protein 8.22 g/dL 6.40 - 8.30
Albumin 4.53 g/dL 3.50 - 5.20
A : G Ratio 1.23 0.90 - 2.00
Calcium, Total 9.56 mg/dL 8.80 - 10.60
Phosphorus 3.35 mg/dL 2.40 - 4.40
*466334874* Page 3 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report

Sodium 137.40 mEq/L 136.00 - 146.00
Potassium 4.99 mEq/L 3.50 - 5.10
Chloride 101.90 mEq/L 101.00 - 109.00
Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1
*466334874* Page 4 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report
COMPLETE BLOOD COUNT;CBC

(Spectrophotometry, Electrical Impedance, Analogical Integration, Calculated & Manual Microscopy)
Hemoglobin 13.90 g/dL 13.00 - 17.00
Packed Cell Volume (PCV) 42.00 % 40.00 - 50.00
RBC Count 4.96 mill/mm3 4.50 - 5.50
MCV 85.00 fL 83.00 - 101.00
MCH 28.00 pg 27.00 - 32.00
MCHC 33.10 g/dL 31.50 - 34.50
Red Cell Distribution Width (RDW) 12.80 % 11.60 - 14.00
Total Leukocyte Count (TLC) 6.50 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)

Segmented Neutrophils 60.20 % 40.00 - 80.00
Lymphocytes 26.50 % 20.00 - 40.00
Monocytes 8.50 % 2.00 - 10.00
Eosinophils 4.80 % 1.00 - 6.00
Basophils 0.00 % <2.00
Absolute Leucocyte Count
Neutrophils 3.91 thou/mm3 2.00 - 7.00
Lymphocytes 1.72 thou/mm3 1.00 - 3.00
Monocytes 0.55 thou/mm3 0.20 - 1.00
Eosinophils 0.31 thou/mm3 0.02 - 0.50
Basophils 0.00 thou/mm3 0.02 - 0.10
Platelet Count 284 thou/mm3 150.00 - 410.00
Mean Platelet Volume 10.1 fL 6.5 - 12.0
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
*466334874* Page 5 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report
blood
2. Test conducted on EDTA whole blood
*466334874* Page 6 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)
HbA1c 5.7 % 4.00 - 5.60
Estimated average glucose (eAG) 117 mg/dL
Interpretation
HbA1c result is suggestive of at risk for Diabetes (Prediabetes)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines
------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------
Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.
---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------
*466334874* Page 7 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report
GLUCOSE, FASTING (F), PLASMA 103.52 mg/dL 70.00 - 100.00

(Hexokinase)
*466334874* Page 8 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report
THYROID PROFILE,TOTAL, SERUM

(CLIA)
T3, Total 1.11 ng/mL 0.60 - 1.81
T4, Total 9.20 µg/dL 4.50 - 11.60
TSH 24.08 µIU/mL 0.35 - 5.50
Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals
Dr.Aditi Agarwal Dr Shruti Chaudhary

MBBS,MD ,DNB DNB, Pathology
Consultant Pathologist Chief of Laboratory
Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
-------------------------------End of report --------------------------------

AHEEEHAPMKHIEMBNLOPBIKNCBILLJCECCIJCIKPLPKEDFEFAPPAHEEEHA
BNFFFNBPAPBGEHMGFGELBOAPAOAHFHAKBKJOBCJKJLELNOJGMPBNFFFNB
GMDAEAFJNOMJBLONHFIAAJHFJHFEHEDBPKPHENFLMKLMOEFLBKHDEHANP
DJEKCOFNBCPIELEAOLOELEPFAFHLAKAFJIFFPAPAKKNJPDNLIDFBKEMEL
KDOKJLFIONFFDIAOJCBGMHBFKENJIBIHKKMDAKEIPLKGKPNGKFFFOKOMH
DDCBBEFCPECAMJFKIMJOOIPBADHFOFAINDFCBKDLBLIKOMNALNEIPOECD
HFIMIJFBELOODLCIEOIECFFHIHAFJBAKOPEPBLMMOJCHKNFMIJNJMDILD
BNFNAMFMBLOEBIOMAANHDMHILKBMFMBJKFCCAMNNIJKDKPNGBNFMBHILL
NKEMANFKHCIGFEIIMOPIHFFKHMJFEKFBJFFLAKPFOEBIOCNKDJPHNEKLJ
OPJCBHFCELIJJDCDNDGOIDJKKDFKPNJHKEPHEDHLNKCKIGEOCJCKHOEMP
BFIKNMFLGKKKNMCMPIABAJEEINMFFFABJNFEBFOFPNDMKPFKEPCIGCIMO
EKICGJFMMLDMIGEMHPCFNNDEIEOPPFOEBEPPBLNOOLJAIANINKONHDICL
MNNNNNEPCGDJMKIAGCFLHDCHJBAHFHAHLKPFCMNLMKJIPFNLAHFHAHIKL
APBBBPAPBCAAEBFLAOBKCEEFAFGCHHCAONFEPLOGOLMHNLNNEDFGHBKHH
HHHHHHHPHPHPHPPPHPPPPHPHPPPPPPPPPPPPHHHPPHHHPHPHHHHHPHPHP
*466334874*
Page 9 of 10
.
Name : Mr. RAHUL

Lab No. : 466334874 Age : 31 Years
S-87 . S-87 .
Test Report
IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com
*466334874*
Page 10 of 10

SL 2024-04-01T130131.04 Report

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

SL 2024-04-01T130131.04 Report

Uploaded by

Copyright:

Available Formats

.

Name : Mr. RAHUL

Test Name Results Units Bio. Ref. Interval

LIPID PROFILE, BASIC, SERUM

Cholesterol Total 214 mg/dL <200.00

Triglycerides 223 mg/dL <150.00

HDL Cholesterol 47 mg/dL >40.00

LDL Cholesterol,Direct 153 mg/dL <100.00

VLDL Cholesterol 45 mg/dL <30.00

Non-HDL Cholesterol 167 mg/dL <130.00

ASCVD Risk Stratification & Treatment goals in Indian population

Treatment Goals as per Lipid Association of India 2020

Name : Mr. RAHUL

Test Name Results Units Bio. Ref. Interval

LIVER PANEL 1; LFT,SERUM

AST (SGOT) 44.0 U/L <50

ALT (SGPT) 92.0 U/L <50

AST:ALT Ratio 0.48 <1.00

GGTP 58.2 U/L <55

Alkaline Phosphatase (ALP) 86.00 U/L 30 - 120

Bilirubin Total 0.48 mg/dL 0.30 - 1.20

Bilirubin Direct 0.08 mg/dL 0.00 - 0.40

Bilirubin Indirect 0.40 mg/dL <1.10

Total Protein 8.22 g/dL 6.40 - 8.30

Albumin 4.53 g/dL 3.50 - 5.20

Name : Mr. RAHUL

Test Name Results Units Bio. Ref. Interval

KIDNEY PANEL; KFT,SERUM

Creatinine 0.84 mg/dL 0.67 - 1.17

GFR Estimated 119 mL/min/1.73m2 >59

Urea 23.70 mg/dL 17.00 - 43.00

Urea Nitrogen Blood 11.07 mg/dL 6.00 - 20.00

Uric Acid 6.09 mg/dL 3.50 - 7.20

Total Protein 8.22 g/dL 6.40 - 8.30

Albumin 4.53 g/dL 3.50 - 5.20

A : G Ratio 1.23 0.90 - 2.00

Calcium, Total 9.56 mg/dL 8.80 - 10.60

Phosphorus 3.35 mg/dL 2.40 - 4.40

Name : Mr. RAHUL

Test Name Results Units Bio. Ref. Interval

Potassium 4.99 mEq/L 3.50 - 5.10

Chloride 101.90 mEq/L 101.00 - 109.00

Name : Mr. RAHUL

COMPLETE BLOOD COUNT;CBC

Hemoglobin 13.90 g/dL 13.00 - 17.00

Packed Cell Volume (PCV) 42.00 % 40.00 - 50.00

RBC Count 4.96 mill/mm3 4.50 - 5.50

MCV 85.00 fL 83.00 - 101.00

MCH 28.00 pg 27.00 - 32.00

MCHC 33.10 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 12.80 % 11.60 - 14.00

Total Leukocyte Count (TLC) 6.50 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Mean Platelet Volume 10.1 fL 6.5 - 12.0

Name : Mr. RAHUL

Name : Mr. RAHUL

Test Name Results Units Bio. Ref. Interval

HbA1c 5.7 % 4.00 - 5.60

Estimated average glucose (eAG) 117 mg/dL

Name : Mr. RAHUL

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA 103.52 mg/dL 70.00 - 100.00

Name : Mr. RAHUL